{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:47:45Z","timestamp":1793818065205,"version":"4.6.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82341032"],"award-info":[{"award-number":["82341032"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81930058"],"award-info":[{"award-number":["81930058"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82402565"],"award-info":[{"award-number":["82402565"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472202"],"award-info":[{"award-number":["82472202"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2023ZD0506500"],"award-info":[{"award-number":["2023ZD0506500"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2023ZD0506506"],"award-info":[{"award-number":["2023ZD0506506"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008081","name":"Southeast University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008081","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.eclinm.2025.103341","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T21:59:07Z","timestamp":1752616747000},"page":"103341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Treatment effects of Xuebijing injection in patients with sepsis by clinical phenotype: a post hoc analysis of the EXIT-SEP trial"],"prefix":"10.1016","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-2800-6142","authenticated-orcid":false,"given":"Xiran","family":"Lou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songqiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2025.103341_bib1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.eclinm.2025.103341_bib2","doi-asserted-by":"crossref","first-page":"e209","DOI":"10.1097\/CCM.0000000000004155","article-title":"The epidemiology of sepsis in Chinese ICUs: a national cross-sectional survey","volume":"48","author":"Xie","year":"2020","journal-title":"Crit Care Med"},{"key":"10.1016\/j.eclinm.2025.103341_bib3","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the global burden of disease study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2025.103341_bib4","article-title":"Review of research progress on the role of the effective components of traditional Chinese medicine in sepsis with multiple organ dysfunction","volume":"9","author":"Zhang","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.eclinm.2025.103341_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejim.2023.10.032","article-title":"Non-conventional immunomodulation in the management of sepsis","volume":"121","author":"Slim","year":"2024","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.eclinm.2025.103341_bib6","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/s41401-023-01224-1","article-title":"Pharmacologically significant constituents collectively responsible for anti-sepsis action of XueBiJing, a Chinese herb-based intravenous formulation","volume":"45","author":"Cheng","year":"2024","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.eclinm.2025.103341_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113301","article-title":"The current evidence for the treatment of sepsis with xuebijing injection: bioactive constituents, findings of clinical studies and potential mechanisms","volume":"265","author":"Li","year":"2021","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.eclinm.2025.103341_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105073","article-title":"The study on the treatment of xuebijing injection (XBJ) in adults with severe or critical corona virus disease 2019 and the inhibitory effect of XBJ against SARS-CoV-2","volume":"160","author":"Ma","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.eclinm.2025.103341_bib9","doi-asserted-by":"crossref","first-page":"e735","DOI":"10.1097\/CCM.0000000000003842","article-title":"XueBiJing injection versus placebo for critically ill patients with severe community-acquired pneumonia: a randomized controlled trial","volume":"47","author":"Song","year":"2019","journal-title":"Crit Care Med"},{"key":"10.1016\/j.eclinm.2025.103341_bib10","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1001\/jamainternmed.2023.0780","article-title":"Effect of an herbal-based injection on 28-day mortality in patients with sepsis: the EXIT-SEP randomized clinical trial","volume":"183","author":"Liu","year":"2023","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.eclinm.2025.103341_bib11","article-title":"Unraveling the impact of therapeutic drug monitoring via machine learning for patients with sepsis","volume":"5","author":"Ates","year":"2024","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.eclinm.2025.103341_bib12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1164\/rccm.202311-2086SO","article-title":"From ICU syndromes to ICU subphenotypes: consensus report and recommendations for developing precision medicine in the ICU","volume":"210","author":"Gordon","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.eclinm.2025.103341_bib13","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.2019.5791","article-title":"Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis","volume":"321","author":"Seymour","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.eclinm.2025.103341_bib14","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13054-024-05004-z","article-title":"Heterogeneity of treatment effect of vilobelimab in COVID-19: a secondary analysis of a randomised controlled trial","volume":"28","author":"van Amstel","year":"2024","journal-title":"Crit Care"},{"key":"10.1016\/j.eclinm.2025.103341_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.775511","article-title":"Revising host phenotypes of sepsis using microbiology","volume":"8","author":"Zhao","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.eclinm.2025.103341_bib16","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.chest.2024.03.006","article-title":"Distribution of acute and chronic kidney disease across clinical phenotypes for sepsis","volume":"166","author":"Molinari","year":"2024","journal-title":"Chest"},{"key":"10.1016\/j.eclinm.2025.103341_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028664","article-title":"Efficacy of xuebijing injection for sepsis (EXIT-SEP): protocol for a randomised controlled trial","volume":"9","author":"Liu","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.eclinm.2025.103341_bib18","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1007\/s00134-023-07239-w","article-title":"Uncovering heterogeneity in sepsis: a comparative analysis of subphenotypes","volume":"49","author":"van Amstel","year":"2023","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.eclinm.2025.103341_bib19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1023\/A:1023949509487","article-title":"Consensus clustering: a resampling-based method for class discovery and visualization of gene expression microarray data","volume":"52","author":"Monti","year":"2003","journal-title":"Mach Learn"},{"key":"10.1016\/j.eclinm.2025.103341_bib20","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13054-025-05256-3","article-title":"Clinical subtypes in critically ill patients with sepsis: validation and parsimonious classifier model development","volume":"29","author":"van Amstel","year":"2025","journal-title":"Crit Care"},{"key":"10.1016\/j.eclinm.2025.103341_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118732","article-title":"XueBiJing injection improves the symptoms of sepsis-induced acute lung injury by mitigating oxidative stress and ferroptosis","volume":"337","author":"Zou","year":"2025","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.eclinm.2025.103341_bib22","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1056\/NEJMra2403213","article-title":"Sepsis and septic shock","volume":"391","author":"Meyer","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2025.103341_bib23","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.joim.2024.08.006","article-title":"Clinical efficacy of xuebijing injection for the treatment of sepsis: a retrospective cohort study","volume":"22","author":"Gong","year":"2024","journal-title":"J Integr Med"},{"key":"10.1016\/j.eclinm.2025.103341_bib24","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.joim.2023.08.004","article-title":"Xuebijing injection, a Chinese patent medicine, against severe pneumonia: current research progress and future perspectives","volume":"21","author":"Zhang","year":"2023","journal-title":"J Integr Med"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537025002731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537025002731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:05:00Z","timestamp":1778904300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537025002731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":24,"alternative-id":["S2589537025002731"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103341","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment effects of Xuebijing injection in patients with sepsis by clinical phenotype: a post hoc analysis of the EXIT-SEP trial","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103341","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103341"}}